Description
BSE announces listing of 3,11,111 new equity shares of Vivo Bio tech Ltd issued to promoters on preferential basis effective August 6, 2025.
Summary
BSE has announced the listing of 3,11,111 new equity shares of Vivo Bio tech Ltd (Scrip Code: 511509) effective from Wednesday, August 6, 2025. These shares were issued to promoters on a preferential basis following conversion of warrants at Rs. 45 per share.
Key Points
- 3,11,111 equity shares of Rs. 10 face value each issued at Rs. 35 premium
- Shares issued to promoters on preferential basis pursuant to warrant conversion
- Trading permitted from August 6, 2025
- Shares rank pari-passu with existing equity shares
- Distribution numbers: 17164817 to 17475927
- ISIN: INE380K01017
Regulatory Changes
No regulatory changes introduced. This is a routine listing notification for new securities.
Compliance Requirements
- Trading members informed of new securities available for trading
- All listed shares subject to existing BSE trading rules and regulations
- Lock-in restrictions apply as specified
Important Dates
- Allotment Date: April 8, 2025
- Trading Commencement: August 6, 2025
- Lock-in Period Ends: February 28, 2027
Impact Assessment
Minimal immediate market impact expected as all 3,11,111 shares are subject to lock-in restrictions until February 28, 2027, preventing immediate trading by promoters. The preferential issue strengthens the company’s equity base without affecting free float availability.
Impact Justification
Routine listing of promoter shares with limited market impact due to lock-in restrictions